Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Touchon

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Geriatric Psychiatry|January 29, 2002
Mild extrapyramidal signs and functional impairment in ageingMarcus Richards, Jacques Touchon, Bernard Ledesert, et al.
International Journal of Geriatric Psychiatry|May 8, 2013
Exploring sleep-related outcomes in patients with mild to moderate Alzheimer's disease initiating acetylcholinesterase inhibitor therapy: the Morpheus surveyChristophe Petiau, Hakki Onen, Antonio Delgado, et al.
Brain and Cognition|May 28, 2002
Text structure and content modulate the recall of patients with dementia of the Alzheimer's typeMarie-Christine Gély-Nargeot, Bernadette Ska, Jacques Touchon
Dementia and Geriatric Cognitive Disorders|October 19, 2006
Revised criteria for mild cognitive impairment: validation within a longitudinal population studySylvaine Artero, Ronald Petersen, Jacques Touchon, et al.
Journal of Alzheimer'S Disease : JAD|October 2, 2023
Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future PerspectivesSolene Guilliot, Serge Gauthier, Jacques Touchon, et al.
Journal of Integrative Neuroscience|March 27, 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer's DiseaseGuillaume Blivet, François J Roman, Julien Delrieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentGuillaume Blivet, Hugo Cavadore, Marwan N Sabbagh, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Neuroprotective effect of a new photobiomodulation technique against Aβ<sub>25-35</sub> peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggestedGuillaume Blivet, Johann Meunier, Francois J Roman, et al.
Journal of Alzheimer'S Disease : JAD|October 3, 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient ComplianceGuillaume Blivet, Aroa Relano-Gines, Mélanie Wachtel, et al.
Annals of Neurology|November 25, 2004
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onsetYves Dauvilliers, Bertrand Carlander, François Rivier, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Geriatric Psychiatry|January 29, 2002
Mild extrapyramidal signs and functional impairment in ageingMarcus Richards, Jacques Touchon, Bernard Ledesert, et al.
International Journal of Geriatric Psychiatry|May 8, 2013
Exploring sleep-related outcomes in patients with mild to moderate Alzheimer's disease initiating acetylcholinesterase inhibitor therapy: the Morpheus surveyChristophe Petiau, Hakki Onen, Antonio Delgado, et al.
Brain and Cognition|May 28, 2002
Text structure and content modulate the recall of patients with dementia of the Alzheimer's typeMarie-Christine Gély-Nargeot, Bernadette Ska, Jacques Touchon
Dementia and Geriatric Cognitive Disorders|October 19, 2006
Revised criteria for mild cognitive impairment: validation within a longitudinal population studySylvaine Artero, Ronald Petersen, Jacques Touchon, et al.
Journal of Alzheimer'S Disease : JAD|October 2, 2023
Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future PerspectivesSolene Guilliot, Serge Gauthier, Jacques Touchon, et al.
Journal of Integrative Neuroscience|March 27, 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer's DiseaseGuillaume Blivet, François J Roman, Julien Delrieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentGuillaume Blivet, Hugo Cavadore, Marwan N Sabbagh, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Neuroprotective effect of a new photobiomodulation technique against Aβ<sub>25-35</sub> peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggestedGuillaume Blivet, Johann Meunier, Francois J Roman, et al.
Journal of Alzheimer'S Disease : JAD|October 3, 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient ComplianceGuillaume Blivet, Aroa Relano-Gines, Mélanie Wachtel, et al.
Annals of Neurology|November 25, 2004
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onsetYves Dauvilliers, Bertrand Carlander, François Rivier, et al.
Pageof 9